A global body set up to accelerate the development of vaccines has pledged $62 million to speed up progress on experimental jabs aimed at tackling the virus behind the Ebola outbreak.

Director-General Jean Kaseya told a virtual press conference that Africa CDC's partners on Monday had pledged almost $500 million to support the fight against the outbreak.

The world has mobilised nearly half a billion dollars to fight the Ebola outbreak gripping Central Africa, yet this “victory” comes with the bitter taste of African inadequacy.…

This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has seen over 900 suspected cases and more than 220…

Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.

Four nurses discharged from DR Congo hospital after recovering from virus

Global health organisation CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebo...

While it marks the 17th Ebola outbreak in the DRC, it is just the third caused by the Bundibugyo strain, for which there are no...

Alors que l’épidémie d’Ebola Bundibugyo continue de progresser en République démocratique du Congo et en Ouganda, plusieurs organisations internationales débloquent des dizaines…

BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…

A global body set up to accelerate the development of vaccines has pledged $62 million to speed up progress on experimental jabs aimed at tackling the virus behind the Ebola…

Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.

With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.

The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.

Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fresh funding to combat a spreading outbreak…

This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.

Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots...

The Serum Institute of India will produce trial doses of Oxford's experimental Ebola vaccine, supported by $8.6 million in CEPI funding to combat Bundibugyo ebolavirus outbreaks.

Three vaccines are being developed to address a rare Ebola strain, which has already claimed nearly 250 lives and poses the risk of becoming the worst outbreak recorded.

Experts have warned that the spread, caused by the Bundibugyo strain of the virus, could surpass the infamous outbreak of Ebola which killed more than 11,000 people between 2014…

Global health groups race to develop a Bundibugyo Ebola vaccine as cases surge in DR Congo and Uganda, with WHO backing a leading rVSV candidate.